These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29356821)

  • 1. The Federal Right to Try Act of 2017-A Wrong Turn for Access to Investigational Drugs and the Path Forward.
    Bateman-House A; Robertson CT
    JAMA Intern Med; 2018 Mar; 178(3):321-322. PubMed ID: 29356821
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
    Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
    Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The strange allure of state "right-to-try" laws.
    Zettler PJ; Greely HT
    JAMA Intern Med; 2014 Dec; 174(12):1885-6. PubMed ID: 25264589
    [No Abstract]   [Full Text] [Related]  

  • 4. Minnesota's Right to Try law.
    Hermer LD
    Minn Med; 2016; 99(1):30-2. PubMed ID: 26897894
    [No Abstract]   [Full Text] [Related]  

  • 5. Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes.
    Finkelstein PE
    AMA J Ethics; 2015 Dec; 17(12):1142-6. PubMed ID: 26698587
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient advocacy. 'Right to Try' laws bypass FDA for last-ditch treatments.
    Servick K
    Science; 2014 Jun; 344(6190):1329. PubMed ID: 24948714
    [No Abstract]   [Full Text] [Related]  

  • 7. "Right to Try" laws.
    Begg CB; Kim K; Neaton JD
    Clin Trials; 2014 Oct; 11(5):519-20. PubMed ID: 25190026
    [No Abstract]   [Full Text] [Related]  

  • 8. Promoting Patient Interests in Implementing the Federal Right to Try Act.
    Lynch HF; Zettler PJ; Sarpatwari A
    JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
    [No Abstract]   [Full Text] [Related]  

  • 9. Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.
    Puthumana J; Miller JE; Kim J; Ross JS
    JAMA Netw Open; 2018 Jun; 1(2):e180283. PubMed ID: 30646072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questions of Safety and Fairness Raised as Right-to-Try Movement Gains Steam.
    Jacob JA
    JAMA; 2015 Aug; 314(8):758-60. PubMed ID: 26244653
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementation of 21st Century Cures Act Expanded Access Policies Requirements.
    Kang S; Chang S; Ross JS; Miller JE
    Clin Pharmacol Ther; 2021 Dec; 110(6):1579-1584. PubMed ID: 34431083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical, legal, and ethical issues in expanded access to investigational drugs.
    Darrow JJ; Sarpatwari A; Avorn J; Kesselheim AS
    N Engl J Med; 2015 Jan; 372(3):279-86. PubMed ID: 25587952
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanded access rules pose quandary for drug developers.
    Mack GS
    Nat Biotechnol; 2009 Oct; 27(10):871-2. PubMed ID: 19816423
    [No Abstract]   [Full Text] [Related]  

  • 14. Right to try?
    Lieu CH; Sorkin A; Messersmith WA
    J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
    [No Abstract]   [Full Text] [Related]  

  • 15. Right-to-try laws: hope, hype, and unintended consequences.
    Bateman-House A; Kimberly L; Redman B; Dubler N; Caplan A
    Ann Intern Med; 2015 Nov; 163(10):796-7. PubMed ID: 26413841
    [No Abstract]   [Full Text] [Related]  

  • 16. The Right to Try: An Overview of Efforts to Obtain Expedited Access to Unapproved Treatment for the Terminally Ill.
    Tsakopoulos A; Han J; Nodler H; Russo V
    Food Drug Law J; 2015; 70(4):617-41. PubMed ID: 26827394
    [No Abstract]   [Full Text] [Related]  

  • 17. Experimental drugs on trial.
    Benderly BL
    Sci Am; 2007 Oct; 297(4):92-9. PubMed ID: 17926760
    [No Abstract]   [Full Text] [Related]  

  • 18. Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs.
    Chapman CR; Eckman J; Bateman-House AS
    Ethics Hum Res; 2020 Jan; 42(1):2-13. PubMed ID: 31967412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission.
    Joffe S; Lynch HF
    N Engl J Med; 2018 Feb; 378(8):695-697. PubMed ID: 29320302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Which efficacy trials for drugs for rare diseases?].
    Traversa G; Trotta F
    Epidemiol Prev; 2017; 41(5-6):318-319. PubMed ID: 29119773
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.